Medical News

RSS

Minority women are disproportionately impacted by the autoimmune disease lupus

There is an urgent need for more education and research to address the fact that minority women are disproportionately impacted by the autoimmune disease lupus

14 May 2004

Project to develop air quality management system for a healthy, comfortable and safe in-vehicle environment

An EU-funded project is developing an innovative air quality management system for a healthy, comfortable and safe in-vehicle environment.

14 May 2004

Embryonic stem cells may hold the key to regenerating damaged heart muscle

Embryonic stem cells may hold the key to regenerating damaged heart muscle, when transplanted within a 3-dimensional scaffold into the infracted heart, according to a new study coming out in June in the Journal of Heart and Lung Transplantation.

14 May 2004

Nonalcoholic beer impart cardiovascular benefits without the negative effects of alcohol

New findings published in the May issue of Alcoholism: Clinical & Experimental Research indicate that nonalcoholic beer may also be able to impart cardiovascular benefits without the negative effects of alcohol, by inhibiting blood coagulation and platelet activation.

14 May 2004

Mechanism that prevents kidney damage in the early stages of diabetes associated with obesity

Northwestern University researchers has identified what they believe is a built-in biological mechanism that prevents kidney damage in the early stages of diabetes associated with obesity.

14 May 2004

Breastfeeding decreases risk of heart disease later in life

A recent UK study of 216 teenagers, published in the Lancet, found that breastfeeding in infancy is likely to reduce the risk of atherosclerosis and cardiovascular disease in later life.

14 May 2004

Chronic Fatigue Syndrome is nearly four times as common in veterans of the first Persian Gulf War as in nonveterans

Chronic Fatigue Syndrome (CFS) is nearly four times as common in veterans of the first Persian Gulf War as in nonveterans, according to a new study.

13 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

Genomed treatment helps bald eagles with West Nile virus encephalitis

GenoMed, Inc. a Next Generation Disease Management company that uses its expertise in genomics to improve clinical outcomes in as many species as possible, announced today that two non-profit groups which care for wild birds with West Nile virus encephalitis, including American bald eagles, will be using the Company's patent-pending treatment this season.

13 May 2004

Better understanding of radiation therapy in the treatment of breast cancer

To help patients understand the importance of radiation therapy in the treatment of breast cancer, the American Society for Therapeutic Radiology and Oncology has published the new patient information brochure Radiation Therapy for Breast Cancer: A Patient’s Guide to Understanding Treatment.

13 May 2004

1 in every 10 children worldwide is obese

In a comprehensive dossier revealing how the global obesity epidemic is affecting children, the International ObesityTaskForce says that one in 10 children is overweight, a total of 155 million. Around 30-45 million within that figure are classified as obese - accounting for 2-3% of the world’s children aged 5-17. A further 22 million younger children are also affected according to previous IOTF global estimates based on WHO data for under fives.

13 May 2004

Key hole colon surgery effective

When performed by experienced surgeons, minimally invasive laparoscopic surgery is a safe and effective alternative to standard open surgery for most patients with cancer that is confined to the colon.

13 May 2004

Cholesterol-lowering drugs could treat multiple sclerosis

Drug treatments for MS are expensive and only partially effective. Recent knowledge that statins promote an anti-inflammatory response from the immune system suggest a potential in the treatment of MS.

13 May 2004

New Canadian drug submission for cannabis-based medicine

GW Pharmaceuticals and Bayer HealthCare, Pharmaceuticals Division - Canada have announced that GW has submitted a New Drug Submission for Sativex®, a cannabis-based medicinal extract product, to Health Canada.

13 May 2004

Biochip technology to revolutionise the pharmaceutical industry

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms.

13 May 2004

FDA knocks back King Pharmaceuticals self-injectible epilepsy product

King Pharmaceuticals, Inc. has reported the receipt by its Meridian Technologies subsidiary of a letter from the U.S. Food and Drug Administration

13 May 2004

Chromosome losses can signal an especially poor response to therapy

A new international study of children with a severe form of acute lymphoblastic leukemia(ALL) shows that certain chromosome losses can signal an especially poor response to therapy, but that other chromosome abnormalities have no effect on treatment survival.

13 May 2004

Patients still prefer doctors to wear white coats

Doctors find their traditional white coats uncomfortable and a germ reservoir, but patients still prefer them to be worn, finds research in Postgraduate Medical Journal.

13 May 2004

West Nile virus found in Illinois mosquitoes

A dead crow and two pools of mosquitoes collected in DuPage County have been identified with West Nile virus, the first positive test results in Illinois this year for the mosquito-borne disease, Dr. Eric E. Whitaker, state public health director, today announced.

13 May 2004

IBM introduces new BioPharmaceutical solution

IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.

13 May 2004